Making tumour diagnosis kinder to kidneys
Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimised a method for tumour diagnosis using radionuclides. Potential side-effects can now be significantly reduced through a molecular trick. The researchers report their results in the current issue of the scientific journal Bioorganic & Medicinal Chemistry.